New Jersey bills · 2026-2027 Regular Session

New Jersey A 4184

Prohibits excessive increases in prices charged for essential off-patent and generic prescription drugs and biological products.

Introduced
In committee
Passed House
Passed Senate
To Governor
Became law

Sponsors

Murphy, Carol A. (Democratic)

Summary

No official summary is available for this bill.

Latest action(Feb 19, 2026): Introduced, Referred to Assembly Health Committee

Read the official text

Text versions

Introduced

Roll-call votes

No recorded votes on this bill.

Actions

Feb 19, 2026 · House
Introduced, Referred to Assembly Health Committee